Publications
Detailed Information
Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hwang, Sang Mee | - |
dc.contributor.author | Kim, Jeong-Ok | - |
dc.contributor.author | Yoo, Young-Mi | - |
dc.contributor.author | Kim, Jin Q. | - |
dc.contributor.author | Song, Eun Young | - |
dc.contributor.author | Park, Myoung Hee | - |
dc.contributor.author | Shin, Sue | - |
dc.date.accessioned | 2012-05-23T04:09:19Z | - |
dc.date.available | 2012-05-23T04:09:19Z | - |
dc.date.issued | 2010-02 | - |
dc.identifier.citation | CLINICAL CHEMISTRY AND LABORATORY MEDICINE; Vol.48 2; 225-230 | ko_KR |
dc.identifier.issn | 1434-6621 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76312 | - |
dc.description.abstract | Background: Anti-cyclic citrullinated peptide (CCP) antibody is emerging as an important diagnostic marker for rheumatoid arthritis (RA). We evaluated the analytical and diagnostic performance of the ARCHITECT anti-CCP (Abbott Diagnostics), a new fully automated chemiluminescent microparticle immunoassay. Methods: Serum samples from 69 patients with RA and 86 non-RA patients were used to evaluate the performance of the ARCHITECT anti-CCP assay, and the results were compared with those of EliA CCP (Phadia). The optimal cut-off value was calculated using receiver operating characteristic (ROC) curve analysis. Results: Within-run and total imprecision (%CV) of the ARCHITECT anti-CCP were < 6% and good linearity was observed over the claimed range. The areas under the ROC curves for the ARCHITECT anti-CCP and EliA CCP were 0.90 and 0.89, respectively. The sensitivity and specificity were 76.8% and 95.3% for the ARCHITECT anti-CCP and 78.3% and 95.3% for EliA CCP using the manufacturer`s cut-off thresholds. Both assays showed sensitivity of 84.1% and specificity of 94.2% using the optimal cut-off values. Conclusions: The analytical performance of the ARCHITECT anti-CCP was satisfactory and diagnostic performance was comparable to that of EliA CCP. The use of optimal cutoff thresholds can yield higher sensitivity with minimal loss of specificity. Clin Chem Lab Med 2010;48: 225-30. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | WALTER DE GRUYTER & CO | ko_KR |
dc.subject | analytical performance | ko_KR |
dc.subject | rheumatoid arthritis | ko_KR |
dc.subject | anti-cyclic citrullinated peptide | ko_KR |
dc.subject | diagnostic performance | ko_KR |
dc.title | Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 김진규 | - |
dc.contributor.AlternativeAuthor | 박명희 | - |
dc.contributor.AlternativeAuthor | 송은영 | - |
dc.contributor.AlternativeAuthor | 김정옥 | - |
dc.contributor.AlternativeAuthor | 황상미 | - |
dc.contributor.AlternativeAuthor | 신수 | - |
dc.contributor.AlternativeAuthor | 유영미 | - |
dc.identifier.doi | 10.1515/CCLM.2010.046 | - |
dc.citation.journaltitle | CLINICAL CHEMISTRY AND LABORATORY MEDICINE | - |
dc.description.citedreference | Lee DM, 2001, LANCET, V358, P903 | - |
dc.description.citedreference | Schellekens GA, 2000, ARTHRITIS RHEUM, V43, P155 | - |
dc.description.citedreference | SHMERLING RH, 1991, AM J MED, V91, P528 | - |
dc.description.citedreference | Mutlu N, 2009, J RHEUMATOL, V36, P491, DOI 10.3899/jrheum.080656 | - |
dc.description.citedreference | Bizzaro N, 2007, CLIN CHEM, V53, P1527, DOI 10.1373/clinchem.2007.087569 | - |
dc.description.citedreference | Coenen D, 2007, CLIN CHEM, V53, P498, DOI 10.1373/clinchem.2006.078063 | - |
dc.description.citedreference | Russell AS, 2006, J RHEUMATOL, V33, P1240 | - |
dc.description.citedreference | *CLIN LAB STAND I, 2003, EP6A CLSI | - |
dc.description.citedreference | Bossuyt PM, 2003, CLIN CHEM, V49, P7 | - |
dc.description.citedreference | *CLIN LAB STAND I, 2005, EP15A2 CLSI | - |
dc.description.citedreference | van Gaalen FA, 2005, ANN RHEUM DIS, V64, P1510, DOI 10.1136/ard.2004.035089 | - |
dc.description.citedreference | Sihvonen S, 2005, J RHEUMATOL, V32, P2089 | - |
dc.description.citedreference | Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744 | - |
dc.description.citedreference | Braun-Moscovici Y, 2006, J RHEUMATOL, V33, P497 | - |
dc.description.citedreference | Turesson C, 2007, ANN RHEUM DIS, V66, P59, DOI 10.1136/ard.2006.054445 | - |
dc.description.citedreference | Nishimura K, 2007, ANN INTERN MED, V146, P797 | - |
dc.description.citedreference | Lutteri L, 2007, CLIN CHIM ACTA, V386, P76, DOI 10.1016/j.cca.2007.08.002 | - |
dc.description.citedreference | Qing YF, 2009, LUPUS, V18, P713, DOI 10.1177/0961203309102817 | - |
dc.description.citedreference | ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315 | - |
dc.description.citedreference | BLAND JM, 1986, LANCET, V1, P307 | - |
dc.description.tc | 0 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.